Posts made in June, 2012

The Ugly Truth: Pharma’s Poorly Placed to Address Payor Pressures

Posted by on Jun 19, 2012 in Cost/Comparative Effectiveness, Health Technology Assessments, Medical Innovation, Payers: Commercial, Payers: Managed Medicaid/Medicare, Payment Reform, Pharmaceuticals, Pricing, Value-based pricing

That was the message from Citi’s healthcare conference held in New York back in February. It’s not a new message, but as with any information that’s vital to a sector’s future, it has...

Learn More

ASCO Highlights New Drugs, ISPOR How They’ll Be Paid For

Posted by on Jun 11, 2012 in Cost/Comparative Effectiveness, Health Technology Assessments, Medical Innovation, Payers: Commercial, Payers: Managed Medicaid/Medicare, Payment Reform, Personalized Medicine, Pharmaceuticals, Pricing, Value-based pricing

  It was perhaps a sign of the changing — but not changed — times that last week’s ASCO meeting, highlighting the next-generation of promising new cancer drugs, overlapped almost perfectly...

Learn More